Showing results (351-360 of 552) with videos related to
Sort By:
Pageof 56
NPJ Parkinson'S Disease|April 22, 2024
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriersBenjamin Roeben, Inga Liepelt-Scarfone, Stefanie Lerche, et al.Frontiers in Psychology|September 25, 2023
Older adults' coping strategies during the COVID-19 pandemic - a longitudinal mixed-methods studyLydia Kastner, Ulrike Suenkel, Gerhard W Eschweiler, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2016
Validation of conversion between mini-mental state examination and montreal cognitive assessmentMichael Lawton, Meike Kasten, Margaret T May, et al.Behavioural Brain Research|April 21, 2012
6-Hydroxydopamine leads to T2 hyperintensity, decreased claudin-3 immunoreactivity and altered aquaporin 4 expression in the striatumBritta Wachter, Sonja Schürger, Andreas Schmid, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 19, 2014
The relation of SMI and the VSEP in a risk sample for neurodegenerative disordersKatja Hagen, Ann-Christine Ehlis, Florian B Haeussinger, et al.Journal of Neuropsychology|October 16, 2018
Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patientsSara Becker, Alena Bäumer, Walter Maetzler, et al.European Journal of Neurology|November 1, 2021
Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's diseaseEva Schaeffer, Benjamin Roeben, Oliver Granert, et al.Neuro-Degenerative Diseases|April 26, 2017
Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: Differences between Cognitive SubtypesBernhard Cerff, Walter Maetzler, Patricia Sulzer, et al.Frontiers in Aging Neuroscience|March 21, 2018
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's DiseaseDaniel Stoessel, Claudia Schulte, Marcia C Teixeira Dos Santos, et al.Neuropsychology|March 20, 2020
Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patientsSara Becker, Alena Bäumer, Walter Maetzler, et al.Pageof 56